# Skin Cancer Prevention With Nicotinamide in Transplant Recipients - Pilot Trial

> **NCT03769285** · PHASE2 · UNKNOWN · sponsor: **Women's College Hospital** · enrollment: 120 (actual)

## Conditions studied

- Non-melanoma Skin Cancer
- Carcinoma, Squamous Cell
- Carcinoma, Basal Cell

## Interventions

- **DRUG:** Nicotinamide
- **DRUG:** Placebo oral capsule

## Key facts

- **NCT ID:** NCT03769285
- **Lead sponsor:** Women's College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-12-03
- **Primary completion:** 2023-12
- **Final completion:** 2023-12
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2023-04-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03769285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03769285, "Skin Cancer Prevention With Nicotinamide in Transplant Recipients - Pilot Trial". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03769285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*